Drug metabolism and pancreatic cancer

John Paul E Flores, Robert B Diasio, Muhammad Wasif Saif

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Pancreatic cancer remains a fatal disease in the majority of patients. The era of personalized medicine is upon us: customizing therapy according to each patient’s individual cancer. Potentially, therapy can be targeted at individuals who would most likely have a favorable response, making it more efficacious and cost effective. This is particularly relevant for pancreatic cancer, which currently portends a very poor prognosis. However, there is much to be done in this field, and more studies are needed to bring this concept to reality.

Original languageEnglish (US)
Pages (from-to)54-61
Number of pages8
JournalAnnals of Gastroenterology
Volume30
Issue number1
DOIs
StatePublished - 2017

Fingerprint

Pancreatic Neoplasms
Precision Medicine
Pharmaceutical Preparations
Costs and Cost Analysis
Therapeutics
Neoplasms

Keywords

  • Chemotherapy
  • Genomic profile
  • Genomics
  • Molecular pancreatic pathogenesis
  • Pancreatic cancer pharmacogenomics
  • Pancreatic exocrine cancer
  • Targeted therapy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Drug metabolism and pancreatic cancer. / Flores, John Paul E; Diasio, Robert B; Saif, Muhammad Wasif.

In: Annals of Gastroenterology, Vol. 30, No. 1, 2017, p. 54-61.

Research output: Contribution to journalArticle

Flores, John Paul E ; Diasio, Robert B ; Saif, Muhammad Wasif. / Drug metabolism and pancreatic cancer. In: Annals of Gastroenterology. 2017 ; Vol. 30, No. 1. pp. 54-61.
@article{9a854c79eeee43788f529b5cac37a426,
title = "Drug metabolism and pancreatic cancer",
abstract = "Pancreatic cancer remains a fatal disease in the majority of patients. The era of personalized medicine is upon us: customizing therapy according to each patient’s individual cancer. Potentially, therapy can be targeted at individuals who would most likely have a favorable response, making it more efficacious and cost effective. This is particularly relevant for pancreatic cancer, which currently portends a very poor prognosis. However, there is much to be done in this field, and more studies are needed to bring this concept to reality.",
keywords = "Chemotherapy, Genomic profile, Genomics, Molecular pancreatic pathogenesis, Pancreatic cancer pharmacogenomics, Pancreatic exocrine cancer, Targeted therapy",
author = "Flores, {John Paul E} and Diasio, {Robert B} and Saif, {Muhammad Wasif}",
year = "2017",
doi = "10.20524/aog.2016.0074",
language = "English (US)",
volume = "30",
pages = "54--61",
journal = "Annals of Gastroenterology",
issn = "1108-7471",
publisher = "Hellenic Society of Gastroenterology",
number = "1",

}

TY - JOUR

T1 - Drug metabolism and pancreatic cancer

AU - Flores, John Paul E

AU - Diasio, Robert B

AU - Saif, Muhammad Wasif

PY - 2017

Y1 - 2017

N2 - Pancreatic cancer remains a fatal disease in the majority of patients. The era of personalized medicine is upon us: customizing therapy according to each patient’s individual cancer. Potentially, therapy can be targeted at individuals who would most likely have a favorable response, making it more efficacious and cost effective. This is particularly relevant for pancreatic cancer, which currently portends a very poor prognosis. However, there is much to be done in this field, and more studies are needed to bring this concept to reality.

AB - Pancreatic cancer remains a fatal disease in the majority of patients. The era of personalized medicine is upon us: customizing therapy according to each patient’s individual cancer. Potentially, therapy can be targeted at individuals who would most likely have a favorable response, making it more efficacious and cost effective. This is particularly relevant for pancreatic cancer, which currently portends a very poor prognosis. However, there is much to be done in this field, and more studies are needed to bring this concept to reality.

KW - Chemotherapy

KW - Genomic profile

KW - Genomics

KW - Molecular pancreatic pathogenesis

KW - Pancreatic cancer pharmacogenomics

KW - Pancreatic exocrine cancer

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85008204091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008204091&partnerID=8YFLogxK

U2 - 10.20524/aog.2016.0074

DO - 10.20524/aog.2016.0074

M3 - Article

AN - SCOPUS:85008204091

VL - 30

SP - 54

EP - 61

JO - Annals of Gastroenterology

JF - Annals of Gastroenterology

SN - 1108-7471

IS - 1

ER -